Delivery Order SPE2DB20D2001-SPE2DB25FPLZA
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award from the Defense Logistics Agency (DLA) is a delivery order for the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,788.38 and runs through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,521.02, is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a medical supply. The award is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is November 22, 2023. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award from the Defense Logistics Agency (DLA) is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract, valued at $7,898.76, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $1,360.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $25,069.68 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 18, 2024. This award is a child under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a firm fixed-price delivery order worth $3,402.55 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,937.71, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $12,471.00 and is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medical product, to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a specialized pharmaceutical product, with a ceiling value of $1,486.06 and a completion date of January 15, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,410.12, is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type, with a performance period ending on January 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...